| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |